(Q43258494)

17 November 2017

Prognostic value of O6-methylguanine-DNA methyltransferase status in glioblastoma patients, assessed by five different methods (English)

1 reference

17 November 2017

1 reference

10

1 reference

17 November 2017

Véronique Quillien

2

0 references

author name string

Lucie Karayan-Tapon

1

1 reference

17 November 2017

Joëlle Guilhot

3

1 reference

17 November 2017

Michel Wager

4

1 reference

17 November 2017

Gaëlle Fromont

5

1 reference

17 November 2017

Stephan Saikali

6

1 reference

17 November 2017

Amandine Etcheverry

7

1 reference

17 November 2017

Abderrahmane Hamlat

8

1 reference

17 November 2017

Delphine Loussouarn

9

1 reference

17 November 2017

Mario Campone

11

1 reference

17 November 2017

François-Marie Vallette

12

1 reference

17 November 2017

Catherine Gratas-Rabbia-Ré

13

1 reference

17 November 2017

20 October 2009

1 reference

Journal of Neuro-Oncology

17 November 2017

1 reference

17 November 2017

97

1 reference

17 November 2017

3

1 reference

17 November 2017

311-322

1 reference

https://scigraph.springernature.com/pub.10.1007/s11060-009-0031-1

17 November 2017

0 references

cites work

Effects of radiotherapy with concomitant and adjuvant temozolomide versus radiotherapy alone on survival in glioblastoma in a randomised phase III study: 5-year analysis of the EORTC-NCIC trial

1 reference

12 December 2020

Quantitation of O6-methylguanine-DNA methyltransferase gene messenger RNA in gliomas by means of real-time RT-PCR and clinical response to nitrosoureas

1 reference

12 December 2020

O6-methyl-guanine-DNA methyltransferase methylation in serum and tumor DNA predicts response to 1,3-bis(2-chloroethyl)-1-nitrosourea but not to temozolamide plus cisplatin in glioblastoma multiforme

1 reference

12 December 2020

Optimization of quantitative MGMT promoter methylation analysis using pyrosequencing and combined bisulfite restriction analysis

1 reference

12 December 2020

Prognostic significance of O6-methylguanine-DNA methyltransferase determined by promoter hypermethylation and immunohistochemical expression in anaplastic gliomas

1 reference

12 December 2020

Methylguanine methyltransferase testing in glioblastoma: when and how?

1 reference

12 December 2020

Correlation between O6-methylguanine-DNA methyltransferase and survival in inoperable newly diagnosed glioblastoma patients treated with neoadjuvant temozolomide

1 reference

12 December 2020

Validation of real-time methylation-specific PCR to determine O6-methylguanine-DNA methyltransferase gene promoter methylation in glioma.

1 reference

12 December 2020

CpG island hypermethylation of the DNA repair enzyme methyltransferase predicts response to temozolomide in primary gliomas

1 reference

12 December 2020

Analysis of Relative Gene Expression Data Using Real-Time Quantitative PCR and the 2−ΔΔCT Method

1 reference

12 December 2020

Relationship between expression of O6-methylguanine-DNA methyltransferase, glutathione-S-transferase π in glioblastoma and the survival of the patients treated with nimustine hydrochloride: An immunohistochemical analysis

1 reference

12 December 2020

Quantitative multiplex methylation-specific PCR assay for the detection of promoter hypermethylation in multiple genes in breast cancer

1 reference

12 December 2020

Anti-O6-methylguanine-methyltransferase (MGMT) immunohistochemistry in glioblastoma multiforme: observer variability and lack of association with patient survival impede its use as clinical biomarker.

1 reference

12 December 2020

A methylation-specific and SYBR-green-based quantitative polymerase chain reaction technique for O6-methylguanine DNA methyltransferase promoter methylation analysis

1 reference

12 December 2020

Pitfalls in the assessment of MGMT expression and in its correlation with survival in diffuse astrocytomas: proposal of a feasible immunohistochemical approach.

1 reference

12 December 2020

Alkylation damage in DNA and RNA--repair mechanisms and medical significance

1 reference

12 December 2020

MGMT promoter methylation and field defect in sporadic colorectal cancer.

1 reference

12 December 2020

Inactivation of the DNA-repair gene MGMT and the clinical response of gliomas to alkylating agents

1 reference

12 December 2020

Methylation of O6-methylguanine DNA methyltransferase and loss of heterozygosity on 19q and/or 17p are overlapping features of secondary glioblastomas with prolonged survival.

1 reference

12 December 2020

Quantitative analysis of O6-alkylguanine-DNA alkyltransferase in malignant glioma.

1 reference

12 December 2020

MGMT immunohistochemical expression and promoter methylation in human glioblastoma

1 reference

12 December 2020

Extent of MGMT promoter methylation correlates with outcome in glioblastomas given temozolomide and radiotherapy

1 reference

12 December 2020

Silencing effect of CpG island hypermethylation and histone modifications on O6-methylguanine-DNA methyltransferase (MGMT) gene expression in human cancer

1 reference

12 December 2020

Predicting lung cancer by detecting aberrant promoter methylation in sputum

1 reference

12 December 2020

O(6)-methylguanine-DNA methyltransferase gene (MGMT) expression in human glioblastomas in relation to patient characteristics and p53 accumulation.

1 reference

12 December 2020

Clinical trial substantiates the predictive value of O-6-methylguanine-DNA methyltransferase promoter methylation in glioblastoma patients treated with temozolomide

1 reference

12 December 2020

Transdominant DeltaTAp73 isoforms are frequently up-regulated in ovarian cancer. Evidence for their role as epigenetic p53 inhibitors in vivo.

1 reference

12 December 2020

O6-methylguanine-DNA methyltransferase methylation and TP53 mutation in malignant astrocytomas and their relationships with clinical course

1 reference

12 December 2020

Integrative genome-wide analysis reveals a robust genomic glioblastoma signature associated with copy number driving changes in gene expression.

1 reference

12 December 2020

O6-methylguanine-DNA methyltransferase expression strongly correlates with outcome in childhood malignant gliomas: results from the CCG-945 Cohort

1 reference

12 December 2020

Correlation between promoter hypermethylation of the O6-methylguanine-deoxyribonucleic acid methyltransferase gene and prognosis in patients with high-grade astrocytic tumors treated with surgery, radiotherapy, and 1-(4-amino-2-methyl-5-pyrimidinyl)

1 reference

12 December 2020

MGMT analysis at DNA, RNA and protein levels in glioblastoma tissue

1 reference

12 December 2020

Down-regulation of O6-methylguanine-DNA methyltransferase gene expression in gliomas by platinum compounds.

1 reference

12 December 2020

Towards Clinical Application of Methylated DNA Sequences as Cancer Biomarkers: A Joint NCI's EDRN and NIST Workshop on Standards, Methods, Assays, Reagents and Tools

1 reference

12 December 2020

Prognostic value of increase in transcript levels of Tp73 DeltaEx2-3 isoforms in low-grade glioma patients

1 reference

12 December 2020

MGMT prognostic impact on glioblastoma is dependent on therapeutic modalities.

1 reference

12 December 2020

Nomograms for predicting survival of patients with newly diagnosed glioblastoma: prognostic factor analysis of EORTC and NCIC trial 26981-22981/CE.3.

1 reference

12 December 2020

Intratumoral homogeneity of MGMT promoter hypermethylation as demonstrated in serial stereotactic specimens from anaplastic astrocytomas and glioblastomas

1 reference

12 December 2020

Induction of the alkyltransferase (MGMT) gene by DNA damaging agents and the glucocorticoid dexamethasone and comparison with the response of base excision repair genes.

1 reference

12 December 2020

MGMT gene silencing and benefit from temozolomide in glioblastoma

1 reference

12 December 2020

O6-methylguanine-DNA methyltranspherase gene expression in gliomas by means of real-time quantitative RT-PCR and clinical response to nitrosoureas

1 reference

12 December 2020

MGMT promoter methylation correlates with survival benefit and sensitivity to temozolomide in pediatric glioblastoma

1 reference

12 December 2020

Loss of the mismatch repair protein MSH6 in human glioblastomas is associated with tumor progression during temozolomide treatment

1 reference

12 December 2020

Correlation of clinical features and methylation status of MGMT gene promoter in glioblastomas

1 reference

12 December 2020

Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma

1 reference

12 December 2020

Human brain tumor O(6)-methylguanine-DNA methyltransferase mRNA and its significance as an indicator of selective chloroethylnitrosourea chemotherapy.

1 reference

12 December 2020

Immunohistochemical study for O6-methylguanine-DNA methyltransferase in the non-neoplastic and neoplastic components of gliomas

1 reference

12 December 2020

10.1007/S11060-009-0031-1

Identifiers

DOI

1 reference

Dimensions Publication ID

17 November 2017

0 references

1 reference